Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy.
about
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationCardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry diseaseHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationHeart disease and stroke statistics--2012 update: a report from the American Heart AssociationHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationRisk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.A primer on arrhythmias in patients with hypertrophic cardiomyopathy.Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile.Semi-automated myocardial segmentation of bright blood multi-gradient echo images improves reproducibility of myocardial contours and T2* determinationEchocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity.Experimental therapies in hypertrophic cardiomyopathyHypertrophic cardiomyopathy: infants, children, and adolescents.Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac deathGenetics of inherited cardiomyopathy.Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study.Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy.Clinical Characteristics and Prognosis of End-stage Hypertrophic CardiomyopathyHeart failure in sub-Saharan Africa.Depression in patients with hypertrophic cardiomyopathy: is there any relation with the risk factors for sudden death?Contemporary treatment of hypertrophic cardiomyopathyHypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy.Advances of cardiovascular MRI in hypertrophic cardiomyopathy.Individualized cardiovascular risk assessment by cardiovascular magnetic resonance.Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure.Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults.Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion.Long-Term Prognosis after Myectomy in Hypertrophic Obstructive Cardiomyopathy with Severe Left Ventricular Hypertrophy.Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.Myocardial Effective Transverse Relaxation Time T 2* is Elevated in Hypertrophic Cardiomyopathy: A 7.0 T Magnetic Resonance Imaging Study.Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.Spirito-Maron Echocardiographic Score: A Marker for Morphological and Physiological Assessment of Patients with Hypertrophic Cardiomyopathy
P2860
Q22306356-EEFB9F91-2449-4159-870A-A6547D870CE3Q28730130-500B8E7F-AF6B-4B29-A818-D7172D5D3189Q29547691-1AF51EF4-A66C-4D74-A0CA-E16863837E34Q29547909-F4E88F02-E439-430E-953D-01EDFF56016CQ30238784-08E84BB8-9557-4BCD-9B3A-B858192765DDQ33158326-D416FBB7-6D1B-46A9-92AB-463710B9D4D6Q33159927-5F00ECE3-3D63-459B-92B0-C87D3067DA43Q33161569-FCEEB157-5900-4148-82B2-E9CC4AF93A97Q33162730-24688919-BEAB-4D74-916B-B0954EE9EADCQ33715326-4DFF661E-8F83-4872-A611-F25CB76EDE7BQ33763883-823FE9BD-6A39-4284-92ED-FBFEC6A7C952Q33882222-4ED5CC3D-8A01-47B4-95D2-3AE476DFF1ABQ33997765-DCA64CCF-1B0C-4410-978A-8620B7D58497Q34244943-632D183B-C4DE-4900-BC69-0C3E69A0D98EQ35431078-066AD0F8-1B56-42D8-BD6C-31AB3CC2A896Q35721684-12840D64-3590-41E7-BCC6-76E985ACDA23Q35954799-473373B7-C373-419C-93DF-B2AD650C8F5FQ36350821-AD7904E3-9391-435F-B411-FCFF0D7E4CFDQ36523287-90A94FD2-D0D3-42A3-B75D-C8D9247AE241Q36928528-5E592566-AD01-4E24-9A95-41112EF27020Q36982732-583853E8-AC08-46B0-90E6-E38CE7289365Q37227838-9E0C2B10-4683-4062-8D7E-EC2999B7D578Q37603719-B6FC0AA9-6D4C-4303-9118-E532C594B260Q37631139-625C7124-B28B-4B47-A925-CC1BFD726568Q37741732-800E3B8C-C532-459E-8731-015AD5FAE5C4Q38135893-26133CB3-D59A-49F5-ADA2-4C6720130EA8Q38206843-42DE06DE-0518-4265-93E0-8823992F20EEQ38336102-C42FF1E4-08CF-495D-9702-2F0680E01D50Q39003149-8BE55CA8-87D4-4F17-BE64-CD94A1504019Q39729560-7A4F3EED-E2E1-483E-AEDB-3E803C12FC0AQ39747435-BAA01EC9-A5D7-4712-A200-668352784F20Q40492999-F42DD3FD-5A3E-4BBC-9BE5-05B36F831035Q41566334-0585ADC2-4841-47F2-A125-61E41A5876E6Q41681436-EE255D6E-9231-4DE1-90A1-3811B20D1EC0Q42180004-888BDDB0-4495-4AFB-9E24-BD53DEDEA407Q50192267-73240049-02AD-420C-A6A9-544FD32D4F25Q50259289-2686F92C-3B81-4D89-81A1-9E5A52A092FFQ52808499-CA74B614-7F0E-4701-A0CB-7C8C1B6C9C6CQ53137860-BD959CDB-3CC5-44A1-BA0A-C74C9AD98F83Q57616965-EAFA5FE9-60F2-4D4F-BA78-C48699B4DEA8
P2860
Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Maximum left ventricular thick ...... h hypertrophic cardiomyopathy.
@ast
Maximum left ventricular thick ...... h hypertrophic cardiomyopathy.
@en
type
label
Maximum left ventricular thick ...... h hypertrophic cardiomyopathy.
@ast
Maximum left ventricular thick ...... h hypertrophic cardiomyopathy.
@en
prefLabel
Maximum left ventricular thick ...... h hypertrophic cardiomyopathy.
@ast
Maximum left ventricular thick ...... h hypertrophic cardiomyopathy.
@en
P2093
P1476
Maximum left ventricular thick ...... h hypertrophic cardiomyopathy.
@en
P2093
Daniela Vargiu
Elena Pedemonte
Iacopo Olivotto
Pasquale Petrone
Roberto Gistri
P304
P356
10.1016/S0735-1097(02)02713-4
P407
P577
2003-01-01T00:00:00Z